1-1 of 1
Ling Y. Kong, MD, PhD
Close
Sort by
Journal Articles

Targeting BCR-ABL and Its Downstream Signaling Cascade as Therapy for Chronic Myelogenous Leukemia.

Nicholas J. Donato, PhD, Ji Wu, MD, Ling Y. Kong, MD, PhD, Feng Meng, MD, Waldemar Priebe, PhD, Moshe Talpaz, MD
Journal: Blood
Blood (2004) 104 (11): 2964.
https://doi.org/10.1182/blood.V104.11.2964.2964
Published: 2004